… To examine whether fentanyl use is associated with buprenorphine treatment outcomes, we
… opioid use among patients initiating treatment with buprenorphine who had either fentanyl …

… Fentanyl was tapered and discontinued in a median of 2.6 … opioid abstinence syndrome
during or after fentanyl taper. One patient experienced significant opioid withdrawal after fentanyl …

… and those who initially tested positive for heroin, whereas patients who tested positive for
fentanyl were less likely to be abstinent at 6 months compared to those who tested negative at …

… fentanyl use, its pharmacological mechanisms and side effects, and the potential clinical
management and prevention of fentanyl-… retention rates and opioid abstinence rates were not …

… were associated with higher levels of abstinence from opioid use (14). The protective benefits
of methadone in people who use fentanyl warrant consideration of strategies that support …

… clearance likely contributes to this phenomenon, and may require extended periods of opioid
abstinence prior to buprenorphine induction, which could be challenging for new patients. …

… can precipitate withdrawal in opioiddependent persons with recent fentanyl use. However, …
despite extended (24–48hours) periods of fentanyl abstinence. Further research is urgently …

… of opioid abstinence for induction into buprenorphine). Despite this window, some
participants may have failed to initiate treatment altogether. Both medications were prescribed in …

… partial agonist (eg, buprenorphine) or antagonist (extended-release naltrexone; XR-NTX)
therapy require a period of opioid abstinence, typically ~12 h for buprenorphine induction, and …

… that MMT is safe, abstinence achievable, and MMT is protective against death among …
the prevalence of fentanyl among those starting MMT for opioid use disorder nor evaluated …